Pregnancy after pituitary surgery does not influence the recurrence of Cushing's disease

Imagem de Miniatura
Arquivos
art_LOUSADA_Pregnancy_after_pituitary_surgery_does_not_influence_the_2022.PDF (456.89 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
TAPIA, Mariuxi Jacqueline Borja
Citação
ENDOCRINE, v.78, n.3, p.552-558, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose Pregnancy is associated with the activation of the hypothalamus-pituitary-adrenal axis, which can cause a misdiagnosis of Cushing's syndrome. The aim of this study is to evaluate the impact of pregnancy after pituitary surgery on the recurrence rate in Cushing's disease (CD) patients. Methods This was a retrospective study in a tertiary center. Between 1990 and 2020, 355 CD patients underwent pituitary surgery. Of those, we included 113 female patients who were <= 45 years old (median age of 32 years, 14-45), PS remission, a follow-up of >= 6 months (median of 122 months, 6-402) and an available obstetric history. Recurrence was defined as the diagnosis of Cushing's syndrome via at least two altered first-line methods. The patients were divided into two subgroups according to pregnancy: no pregnancy or pregnancy prior to CD diagnosis (NP/PP) and pregnancy after CD pituitary surgery (PA). Results Overall, recurrence occurred in 43 out of 113 patients (38%). A higher recurrence rate was seen in the PA subgroup (11/22, 50%), but there was no significant difference between the NP/PP subgroup (32/91, 35%). No difference in survival-free recurrence (SFR) was found between NP/PP and PA subgroups. The lower SFR was related to a higher PS plasma ACTH and normal pituitary at pathological analyses. Conclusions There was no difference in the recurrence rate in patients according to pregnancy history. Other studies with higher numbers of patients are needed to confirm these data.
Palavras-chave
Cushing's disease, Pituitary surgery, Pregnancy, Recurrence
URI
https://observatorio.fm.usp.br/handle/OPI/50361
Referências
  1. Alexandraki KI, 2013, EUR J ENDOCRINOL, V168, P639, DOI 10.1530/EJE-12-0921
  2. Bronstein MD, 2015, EUR J ENDOCRINOL, V173, pR85, DOI 10.1530/EJE-14-1130
  3. CARR BR, 1981, AM J OBSTET GYNECOL, V139, P416, DOI 10.1016/0002-9378(81)90318-5
  4. DEMEYPONSART E, 1982, J STEROID BIOCHEM, V16, P165, DOI 10.1016/0022-4731(82)90163-7
  5. Fleseriu M, 2021, LANCET DIABETES ENDO, V9, P847, DOI 10.1016/S2213-8587(21)00235-7
  6. Jornayvaz FR, 2011, J CLIN ENDOCR METAB, V96, pE658, DOI 10.1210/jc.2010-2235
  7. Lindsay JR, 2005, ENDOCR REV, V26, P775, DOI 10.1210/er.2004-0025
  8. Lindsay JR, 2005, J CLIN ENDOCR METAB, V90, P3077, DOI 10.1210/jc.2004-2361
  9. Machado MC, 2016, J ENDOCRINOL INVEST, V39, P1401, DOI 10.1007/s40618-016-0504-y
  10. Machado MC, 2016, ARCH ENDOCRIN METAB, V60, P267, DOI 10.1590/2359-3997000000174
  11. Nieman LK, 2015, J CLIN ENDOCR METAB, V100, P2807, DOI 10.1210/jc.2015-1818
  12. Palejwala SK, 2018, PITUITARY, V21, P584, DOI 10.1007/s11102-018-0910-6
  13. Patil CG, 2008, J CLIN ENDOCR METAB, V93, P358, DOI 10.1210/jc.2007-2013
  14. Romanholi DJC, 2008, CLIN ENDOCRINOL, V69, P117, DOI 10.1111/j.1365-2265.2007.03168.x
  15. Pivonello R, 2015, ENDOCR REV, V36, P385, DOI 10.1210/er.2013-1048
  16. Pivonello R, 2014, J ENDOCRINOL INVEST, V37, P99, DOI 10.1007/s40618-013-0019-8
  17. Tang KY, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00305
  18. Tirabassi G, 2010, J CLIN ENDOCR METAB, V95, P1115, DOI 10.1210/jc.2009-1146
  19. Wetzka B, 2003, EXP CLIN ENDOCR DIAB, V111, P154, DOI 10.1055/s-2003-39778

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/25
Artigos e Materiais de Revistas Científicas - LIM/42
Artigos e Materiais de Revistas Científicas - LIM/51
Carregar mais